J&J, Merck, Endo Probed Over Pharmacy Benefit Managers

Law360, Los Angeles (May 10, 2016, 10:35 PM EDT) -- Federal prosecutors in Manhattan have asked drugmakers including Johnson & Johnson, Merck and Endo for information regarding contracts with pharmacy benefit managers in connection with a False Claims Act investigation, according to regulatory filings.

In its quarterly report filed Tuesday with the U.S. Securities and Exchange Commission, J&J disclosed that its Janssen Pharmaceuticals unit in March received a civil investigative demand from the U.S. attorney's office for the Southern District of New York asking for information about Janssen's contractual relationships with pharmacy benefit managers for unspecified products from January 2006 to the present.

"The demand was issued in connection with an...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!